Literature DB >> 24510478

Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis.

G Tian1, J-N Liang, H-F Pan, D Zhou.   

Abstract

AIM: Published data regarding the association of leptin levels with rheumatoid arthritis (RA) are contradictory. To derive a more precise estimation of this relationship, a meta-analysis was performed.
METHODS: Published literature from PubMed, Embase and Cochrane Library was obtained. Pooled standard mean difference (SMD) with 95 % confidence interval (CI) was calculated using fixed-effects or random-effect model analysis. Heterogeneity among studies was evaluated using the Cochran Q and I (2) statistics. The study quality was assessed by the Newcastle-Ottawa scale.
RESULTS: A total of 20 studies including 998 RA patients and 692 controls were finally included in the meta-analysis. Compared to healthy controls, RA patients had significantly higher leptin levels (SMD 1.19, 95 % CI 0.59-1.79). Subgroup analyses showed that region, race, age, body mass index (BMI), disease duration and disease activity were positively associated with plasma leptin levels in RA patients. Sensitivity analysis showed no significant change when any one study was excluded. Publication bias was also undetected.
CONCLUSIONS: The present meta-analysis suggested that leptin levels were higher in RA patients than those in healthy controls, which may be subject to different region, race, age, BMI, disease duration and disease activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510478     DOI: 10.1007/s11845-014-1072-9

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  31 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Serum leptin levels in patients with rheumatoid arthritis.

Authors:  M Salazar-Páramo; M González-Ortiz; L González-López; A Sánchez-Ortiz; I C Valera-González; E Martínez-Abundis; B R Balcázar-Muñoz; A García-González; J I Gámez-Nava
Journal:  J Clin Rheumatol       Date:  2001-02       Impact factor: 3.517

3.  Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis.

Authors:  H J Anders; M Rihl; A Heufelder; O Loch; M Schattenkirchner
Journal:  Metabolism       Date:  1999-06       Impact factor: 8.694

4.  Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.

Authors:  Hilal Maradit Kremers; Paulo J Nicola; Cynthia S Crowson; Karla V Ballman; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2004-11

5.  Serum leptin levels in rheumatoid arthritis and relationship with disease activity.

Authors:  Rezzan Gunaydin; Taciser Kaya; Aysenur Atay; Nese Olmez; Aysel Hur; Mehmet Koseoglu
Journal:  South Med J       Date:  2006-10       Impact factor: 0.954

Review 6.  Leptin, from fat to inflammation: old questions and new insights.

Authors:  Miguel Otero; Rocío Lago; Francisca Lago; Felipe F Casanueva; Carlos Dieguez; Juan Jesús Gómez-Reino; Oreste Gualillo
Journal:  FEBS Lett       Date:  2005-01-17       Impact factor: 4.124

7.  Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity.

Authors:  Bozena Targońska-Stepniak; Maria Majdan; Magdalena Dryglewska
Journal:  Rheumatol Int       Date:  2007-10-30       Impact factor: 2.631

8.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

9.  Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis.

Authors:  Arzu Seven; Savaş Güzel; Mahmure Aslan; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2008-11-14       Impact factor: 2.631

10.  Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist.

Authors:  Magdalena Kopec-Medrek; Anna Kotulska; Malgorzata Widuchowska; Marcin Adamczak; Andrzej Więcek; Eugene J Kucharz
Journal:  Rheumatol Int       Date:  2011-11-03       Impact factor: 2.631

View more
  9 in total

1.  Leptin as an obesity marker in rheumatoid arthritis.

Authors:  Maria Fernanda Brandão de Resende Guimarães; Marcus Vinícius Melo de Andrade; Carla Jorge Machado; Érica Leandro Marciano Vieira; Maria Raquel da Costa Pinto; Antônio Lúcio Teixeira Júnior; Adriana Maria Kakehasi
Journal:  Rheumatol Int       Date:  2018-06-11       Impact factor: 2.631

Review 2.  Adipokines in bone disease.

Authors:  Elena Neumann; Susann Junker; Georg Schett; Klaus Frommer; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

3.  Leptin as an open secret in the physiopathology of rheumatic diseases.

Authors:  Mónica Vázquez-Del Mercado; Erika A Martínez-García
Journal:  Clin Rheumatol       Date:  2020-01-11       Impact factor: 2.980

4.  Serum leptin levels in pemphigus: a case control study.

Authors:  Nikoo Mozafari; Reza M Robati; Shima Younespour
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

5.  Tocilizumab Increases Body Weight and Serum Adipokine Levels in Patients with Rheumatoid Arthritis Independently of Their Treatment Response: a Retrospective Cohort Study.

Authors:  In Ah Choi; Akira Sagawa; Eun Young Lee; Eun Bong Lee; Yeong Wook Song
Journal:  J Korean Med Sci       Date:  2020-06-08       Impact factor: 2.153

Review 6.  Mini-Review: The Contribution of Adipokines to Joint Inflammation in Inflammatory Rheumatic Diseases.

Authors:  Eric Toussirot
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-23       Impact factor: 5.555

7.  Serum leptin and serum leptin/serum leptin receptor ratio imbalance in obese rheumatoid arthritis patients positive for anti-cyclic citrullinated peptide antibodies.

Authors:  Eduardo Gómez-Bañuelos; Rosa Elena Navarro-Hernández; Fernanda Corona-Meraz; Perla Monserrat Madrigal-Ruíz; Beatríz Teresita Martín-Marquez; Oscar Enrique Pizano-Martinez; Jorge Aguilar-Arreola; Paul Jacob Perez-Cruz; Hector Macias-Reyes; Laura Gonzalez-Lopez; Jorge Ivan Gamez-Nava; Mario Salazar-Páramo; Monica Vazquez-del Mercado
Journal:  Arthritis Res Ther       Date:  2015-11-20       Impact factor: 5.156

8.  Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis.

Authors:  Elinoar Hoffman; Michal A Rahat; Joy Feld; Muna Elias; Itzhak Rosner; Lisa Kaly; Idit Lavie; Tal Gazitt; Devy Zisman
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

9.  Re-evaluation of serum leptin and adiponectin concentrations normalized by body fat mass in patients with rheumatoid arthritis.

Authors:  Kazuhisa Chihara; Naoki Hattori; Norihiro Ichikawa; Takeshi Matsuda; Takanori Saito
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.